Xinjun Liang

1.0k total citations
46 papers, 528 citations indexed

About

Xinjun Liang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinjun Liang has authored 46 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 13 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinjun Liang's work include Cancer, Lipids, and Metabolism (9 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Xinjun Liang is often cited by papers focused on Cancer, Lipids, and Metabolism (9 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Xinjun Liang collaborates with scholars based in China, Hong Kong and Canada. Xinjun Liang's co-authors include Yanyan Liu, Yueqiang Li, Gang Xu, Ying Zhang, Yifei Ma, Shaozhong Wei, Ping Lü, Kun Wang, Shuai Huang and Kun Wang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Xinjun Liang

45 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinjun Liang China 13 212 115 114 86 67 46 528
Yıldız Okuturlar Türkiye 13 149 0.7× 38 0.3× 103 0.9× 72 0.8× 44 0.7× 55 475
Bimin Shi China 13 304 1.4× 158 1.4× 130 1.1× 76 0.9× 128 1.9× 26 701
Senarath Edirimanne Australia 14 264 1.2× 46 0.4× 158 1.4× 109 1.3× 72 1.1× 37 729
Cibo Huang China 15 71 0.3× 162 1.4× 162 1.4× 36 0.4× 74 1.1× 45 657
Han Jo Kim South Korea 16 265 1.3× 53 0.5× 248 2.2× 131 1.5× 46 0.7× 47 642
Xiaona Chang China 12 110 0.5× 37 0.3× 149 1.3× 51 0.6× 52 0.8× 47 438
Nivedita Arora United States 15 297 1.4× 52 0.5× 235 2.1× 103 1.2× 118 1.8× 38 672
Mohammad Ali Mashhadi Iran 18 152 0.7× 116 1.0× 329 2.9× 154 1.8× 88 1.3× 67 840
Csilla Sipeky Hungary 18 141 0.7× 187 1.6× 183 1.6× 81 0.9× 42 0.6× 39 723
Çiğdem Usul Afşar Türkiye 14 178 0.8× 68 0.6× 123 1.1× 63 0.7× 45 0.7× 50 438

Countries citing papers authored by Xinjun Liang

Since Specialization
Citations

This map shows the geographic impact of Xinjun Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjun Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjun Liang more than expected).

Fields of papers citing papers by Xinjun Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinjun Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjun Liang. The network helps show where Xinjun Liang may publish in the future.

Co-authorship network of co-authors of Xinjun Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinjun Liang. A scholar is included among the top collaborators of Xinjun Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinjun Liang. Xinjun Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jie, et al.. (2024). Suicide among lymphoma patients. Journal of Affective Disorders. 360. 97–107. 2 indexed citations
2.
Ma, Fei, Jingfen Wang, Herui Yao, et al.. (2024). Updated safety and antitumor activity of BB-1701 from study 101 in the multiple dose level cohort of patients with locally advanced/metastatic HER2-low expressing breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1110–1110. 2 indexed citations
3.
4.
Wang, Feng, Junjie Peng, Xinjun Liang, et al.. (2024). First-line serplulimab plus HLX04 and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study.. Journal of Clinical Oncology. 42(16_suppl). 3569–3569. 2 indexed citations
5.
Liu, Yirui, Xinjun Liang, Bin Yang, Yuan Wu, & Qian Yu. (2024). Impact of Baduanjin Qigong Exercise on Fatigue in Patients with Lung Cancer: A Randomized Controlled Trial. Journal of Palliative Medicine. 27(12). 1648–1652. 2 indexed citations
6.
Liu, Tianshu, Yu Yang, Shenghua Ni, et al.. (2024). 1456P First in human phase I/II trial of claudin 18.2 ADC RC118 in patients with advanced gastric/gastroesophageal junction cancer. Annals of Oncology. 35. S903–S903. 1 indexed citations
7.
Chen, Runzhi, Yang Liu, Sheng Hu, et al.. (2022). Apatinib plus 5-fluorouracil as a third or subsequent-line treatment option for metastatic colorectal cancer: a phase-II, single-arm, prospective study. Annals of Translational Medicine. 10(2). 100–100. 6 indexed citations
8.
Zhou, Xiaomei, et al.. (2022). Overexpression of HMGB3 and its prognostic value in breast cancer. Frontiers in Oncology. 12. 1048921–1048921. 10 indexed citations
9.
Li, Siwei, Guoliang Pi, Yong Zeng, et al.. (2022). Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma. International Immunopharmacology. 113(Pt A). 109323–109323. 9 indexed citations
10.
Luo, Bo, Xinhong Wu, Hongmei Zheng, et al.. (2021). Nuclear Her2 contributes to paclitaxel resistance in breast cancer cells. Anti-Cancer Drugs. 32(7). 709–716. 6 indexed citations
11.
Lü, Ping, Yifei Ma, Shaozhong Wei, & Xinjun Liang. (2021). A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer. Frontiers in Medicine. 8. 621592–621592. 14 indexed citations
12.
Liang, Xinjun, Shuang Yao, Ping Lü, et al.. (2021). The Prognostic Value of New Index (LANR) Composed of Pre-operative Lymphocytes, Albumin, and Neutrophils in Patients With Resectable Colorectal Cancer. Frontiers in Oncology. 11. 610264–610264. 9 indexed citations
13.
Lü, Ping, Yifei Ma, Shaozhong Wei, & Xinjun Liang. (2021). The dual role of complement in cancers, from destroying tumors to promoting tumor development. Cytokine. 143. 155522–155522. 16 indexed citations
14.
15.
Dong, Shuang, Xuebo Hu, Jing Zhang, et al.. (2020). Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2. Frontiers in Oncology. 10. 1555–1555. 5 indexed citations
16.
Chang, Xiaoyan, Qian Yang, Conghui Zhang, et al.. (2019). Roles for VEGF‐C/NRP–2 axis in regulating renal tubular epithelial cell survival and autophagy during serum deprivation. Cell Biochemistry and Function. 37(4). 290–300. 12 indexed citations
17.
Wang, Kun, Juan Zhan, Xinjun Liang, et al.. (2019). GSPE alleviates renal fibrosis by inhibiting the activation of C3/ HMGB1/ TGF-β1 pathway. Chemico-Biological Interactions. 316. 108926–108926. 18 indexed citations
18.
Pang, Shuo, Xingchen Yu, Shaozhong Wei, et al.. (2017). The predictive value of integrated inflammation scores in the survival of patients with resected hepatocellular carcinoma: A Retrospective Cohort Study. International Journal of Surgery. 42. 170–177. 18 indexed citations
19.
Wang, Wenhao, Peng Wang, Shiyuan Li, et al.. (2014). Methylprednisolone inhibits the proliferation and affects the differentiation of rat spinal cord-derived neural progenitor cells cultured in low oxygen conditions by inhibiting HIF-1α and Hes1 in vitro. International Journal of Molecular Medicine. 34(3). 788–795. 5 indexed citations
20.
Liang, Wenjia, Shuo Feng, Yan Zhang, et al.. (2012). Response to the first wave of pandemic (H1N1) 2009: Experiences and lessons learnt from China. Public Health. 126(5). 427–436. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yıldız Okuturlar Breakdown of academic impact, for papers by Bimin Shi Breakdown of academic impact, for papers by Senarath Edirimanne Breakdown of academic impact, for papers by Cibo Huang Breakdown of academic impact, for papers by Han Jo Kim Breakdown of academic impact, for papers by Xiaona Chang Breakdown of academic impact, for papers by Nivedita Arora Breakdown of academic impact, for papers by Mohammad Ali Mashhadi Breakdown of academic impact, for papers by Csilla Sipeky Breakdown of academic impact, for papers by Çiğdem Usul Afşar
Rankless by CCL
2026